✦ LIBER ✦
Novel multimodality biologic response modifier therapy, including bexarotene and long-wave ultraviolet A for a patient with refractory stage IVa cutaneous T-cell lymphoma
✍ Scribed by Michael Shapiro; Alain H. Rook; Michael S. Lehrer; Jacqueline M. Junkins-Hopkins; Lars E. French; Carmela C. Vittorio
- Book ID
- 117845542
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 275 KB
- Volume
- 47
- Category
- Article
- ISSN
- 1097-6787
No coin nor oath required. For personal study only.